SCHEMBL13729909

SCHEMBL13729909

O=C(O)C1CC1(C(=O)Cl)C(=O)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.39
CYP2C19 P33261 5/20 0.36
GRM4 Q14833 6/20 0.36
CYP1A2 P05177 4/20 0.36
CYP2D6 P10635 3/20 0.36
ALOX15 P16050 3/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
GRM8 O00222 2/20 0.36
GRM6 O15303 2/20 0.36
CYP2C9 P11712 1/20 0.36
KDM4E B2RXH2 1/20 0.36
APLNR P35414 1/20 0.33
LMNA P02545 3/20 0.32
BLM P54132 2/20 0.32
TSHR P16473 2/20 0.32
RAB9A P51151 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628164 0.81
SCHEMBL2775001 0.78 GRM4 (0.44) SLC6A4CYP2C19GRM4CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL28453447 0.76 GRM4 (0.42) SLC6A4CYP2C19GRM4CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL3272762 0.76 GRM4 (0.42) SLC6A4CYP2C19GRM4CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL628165 0.76 GRM4 (0.42) SLC6A4CYP2C19GRM4CYP1A2CYP2D6
SCHEMBL10532278 0.74 APLNR (0.39) SLC6A4CYP2C19GRM4CYP1A2CYP2D6
SCHEMBL21019008 0.69
SCHEMBL302705 0.69
SCHEMBL30723104 0.69 SLC6A4 (0.31) SLC6A4
SCHEMBL29618225 0.69 MAPT (0.37) SLC6A4CYP2C19GRM4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2705039-A2 BROMODOMAIN INHIBITORS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2014-03-12 EP disclosed
WO-2012151512-A2 BROMODOMAIN INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. (US) 2012-11-08 WO disclosed